Skip to content
10-Q

Quarterly Report

Five Prime Therapeutics, Inc.

0001564590-20-050006

← back to feed
Filed
Nov 3, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 30, 2020 38.04M sh
Capex Q3 2020 · Sep 30, 2020 $44K
Capex Q3 2020 · Sep 30, 2019 $1.58M
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$51.39M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$84.25M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $36.02M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $55.8M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $48.93M
Cash And Equivalents Q3 2020 · Dec 31, 2018 $43.95M
Stockholders Equity Q3 2020 · Sep 30, 2020 $95.23M
Stockholders Equity Q3 2020 · Jun 30, 2020 $119.94M
Stockholders Equity Q3 2020 · Mar 31, 2020 $134.54M
Stockholders Equity Q3 2020 · Dec 31, 2019 $150.47M
Stockholders Equity Q3 2020 · Sep 30, 2019 $178.43M
Stockholders Equity Q3 2020 · Jun 30, 2019 $206.61M
Stockholders Equity Q3 2020 · Mar 31, 2019 $234.33M
Stockholders Equity Q3 2020 · Dec 31, 2018 $265.14M
Current Liabilities Q3 2020 · Sep 30, 2020 $23.05M
Current Liabilities Q3 2020 · Dec 31, 2019 $23.02M
Current Assets Q3 2020 · Sep 30, 2020 $123.28M
Current Assets Q3 2020 · Dec 31, 2019 $166.72M
Total Assets Q3 2020 · Sep 30, 2020 $160.38M
Total Assets Q3 2020 · Dec 31, 2019 $224.14M
Sga Expense Q3 2020 · Sep 30, 2020 $13.71M
Sga Expense Q3 2020 · Sep 30, 2020 $32.2M
Sga Expense Q3 2020 · Sep 30, 2019 $13.21M
Sga Expense Q3 2020 · Sep 30, 2019 $33.38M
Rd Expense Q3 2020 · Sep 30, 2020 $21.45M
Rd Expense Q3 2020 · Sep 30, 2020 $52.58M
Rd Expense Q3 2020 · Sep 30, 2019 $26.95M
Rd Expense Q3 2020 · Sep 30, 2019 $88.13M
Net Income Q3 2020 · Sep 30, 2020 −$26.42M
Net Income Q3 2020 · Sep 30, 2020 −$63.48M
Net Income Q3 2020 · Jun 30, 2020 −$16.94M
Net Income Q3 2020 · Mar 31, 2020 −$20.12M
Net Income Q3 2020 · Sep 30, 2019 −$36.07M
Net Income Q3 2020 · Sep 30, 2019 −$105.85M
Net Income Q3 2020 · Jun 30, 2019 −$34.39M
Net Income Q3 2020 · Mar 31, 2019 −$35.39M
Operating Income Q3 2020 · Sep 30, 2020 −$33.11M
Operating Income Q3 2020 · Sep 30, 2020 −$70.89M
Operating Income Q3 2020 · Sep 30, 2019 −$37.17M
Operating Income Q3 2020 · Sep 30, 2019 −$109.84M